Abstract
Malignant mesothelioma (MM) is an aggressive neoplasm with poor prognosis. The Dako PD-L1 22C3 and 28-8 pharmDx assays are approved by the US Food and Drug Administration (FDA) as companion and complementary diagnostics for the anti-PD-1 drugs pembrolizumab and nivolumab, respectively. Data from multiple clinical trials indicate that immunotherapy has antitumor activity in advanced malignant pleural (MPM) and peritoneal mesothelioma (MPeM). However, large studies of PD-L1 expression in MM using the FDA-approved anti-PD-L1 assays are lacking. We stained tissue microarray sections (N = 125; 112 MPM and 13 MPeM) using 2 FDA-approved clinical immunohistochemical makers for PD-L1 expression: Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx. Overall, 22% (27/125) of MMs were positive using the 22C3 assay, whereas 27% (32/117) were positive using the 28-8 assay, using a tumor proportion score cutoff of 1%. Tumor cell PD-L1 expression was strongly correlated with PD-L1 expression on tumor-associated immune cells. No significant difference in PD-L1 expression was observed by patient sex, age, treatment history, pathologic stage, or histologic subtype. However, the proportion of cases positive for PD-L1 expression was higher among MPe...Continue Reading
References
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nicholas J VogelzangPaolo Paoletti
Oct 27, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Michael T Milano, Hong Zhang
Jun 14, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Aaron Scott MansfieldEugene D Kwon
Nov 18, 2014·The New England Journal of Medicine·Caroline RobertPaolo A Ascierto
Mar 17, 2015·PloS One·Susana CedrésEnriqueta Felip
Jun 2, 2015·The New England Journal of Medicine·Julie BrahmerDavid R Spigel
Sep 26, 2015·The New England Journal of Medicine·Robert J MotzerUNKNOWN CheckMate 025 Investigators
Sep 29, 2015·The New England Journal of Medicine·Hossein BorghaeiJulie R Brahmer
Nov 13, 2015·Expert Review of Molecular Diagnostics·Jan Trøst Jørgensen
Jan 1, 2016·Lancet·Gérard ZalcmanUNKNOWN French Cooperative Thoracic Intergroup (IFCT)
Mar 17, 2016·Human Pathology·Christelle Combaz-LairSylvie Lantuejoul
Mar 31, 2016·The Oncologist·Joohee SulRichard Pazdur
Jun 12, 2016·Journal of Translational Medicine·Woo Young SunJa Seung Koo
Jun 23, 2016·Applied Immunohistochemistry & Molecular Morphology : AIMM·Charlotte RoachKarina Kulangara
Oct 25, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Swati KhannaRaffit Hassan
Sep 27, 2016·Molecular Diagnosis & Therapy·John CogswellDiana M Cardona
Oct 11, 2016·The New England Journal of Medicine·Robert L FerrisMaura L Gillison
Oct 11, 2016·The New England Journal of Medicine·Martin ReckUNKNOWN KEYNOTE-024 Investigators
Nov 9, 2016·Clinical Epidemiology·Jennifer L Beebe-DimmerShirish Gadgeel
Mar 16, 2017·The Lancet Oncology·Evan W AlleyEmilie van Brummelen
Jun 18, 2017·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·S Valmary-DeganoUNKNOWN French RENAPE Network
Nov 18, 2017·Oncoimmunology·Simone B S P TerraAnja C Roden
Apr 17, 2018·The New England Journal of Medicine·Matthew D HellmannLuis Paz-Ares
May 19, 2018·The Lancet. Respiratory Medicine·Luana CalabròMichele Maio
Jun 17, 2018·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Josine Quispel-JanssenPaul Baas
Citations
Sep 3, 2018·Virchows Archiv : an International Journal of Pathology·Spasenija Savic Prince, Lukas Bubendorf
Oct 31, 2018·Seminars in Immunopathology·Emmett V Schmidt
Sep 4, 2019·Diagnostic Pathology·Magdalena ZajacJill Walker
Nov 26, 2019·Head & Neck·Jaimin J PatelTerry A Day
Feb 3, 2019·Journal for Immunotherapy of Cancer·Sarabjot PablaCarl Morrison
Sep 5, 2019·Archives of Pathology & Laboratory Medicine·Fatemeh DerakhshanAndrew Churg
Sep 21, 2019·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Stephanie MullerJennifer L Sauter
Apr 12, 2020·Cancers·Fabio NicoliniMassimiliano Mazza
Apr 16, 2020·Cancers·Joëlle S NaderDaniel L Pouliquen
Apr 28, 2020·PloS One·Magdalena ZajacJill Walker
Jun 9, 2019·BMC Cancer·Akihito TsunodaMasamichi Mineshita
Jul 25, 2019·Archives of Pathology & Laboratory Medicine·Megan L TroxellYaping Wu
Jun 28, 2020·Journal of Clinical Pathology·Gabriel S KrigsfeldDavid Huron
Dec 24, 2019·Frontiers in Oncology·Gerard J ChuJohn E J Rasko
Nov 21, 2020·Journal of Cancer Research and Clinical Oncology·Roberta CarosioMaria Pia Pistillo
Jan 26, 2021·Cancer Cytopathology·Mohammed S I MansourAnnika Dejmek
Oct 17, 2020·Therapeutic Advances in Medical Oncology·Liu JinZhongwen Chen
Oct 27, 2020·British Journal of Cancer·Michael G WhiteOliver S Eng
Mar 18, 2020·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Jordi RemonGiorgio V Scagliotti
Apr 10, 2021·The Lancet. Respiratory Medicine·Timothy A YapHedy L Kindler
May 4, 2021·Frontiers in Immunology·Wenping MaYing Zhang
Jun 27, 2021·Cancer Treatment Reviews·Kaushal ParikhJordi Remon
Aug 7, 2021·JAMA Network Open·Kanwal RaghavGauri Varadhachary
Jul 16, 2021·Cancer Discovery·Kanwal RaghavDaniel M Halperin